Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sunshine Biopharma (SBFM) Long-Term Debt Issuances (2016 - 2021)

Sunshine Biopharma's Long-Term Debt Issuances history spans 8 years, with the latest figure at $1.4 million for Q3 2021.

  • For Q3 2021, Long-Term Debt Issuances rose 168.39% year-over-year to $1.4 million; the TTM value through Dec 2021 reached $5.1 million, up 204.85%, while the annual FY2021 figure was $3.3 million, 98.21% up from the prior year.
  • Long-Term Debt Issuances reached $1.4 million in Q3 2021 per SBFM's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $2.6 million in Q2 2021 to a low of -$370467.0 in Q4 2017.
  • Average Long-Term Debt Issuances over 5 years is $429048.6, with a median of $202253.5 recorded in 2019.
  • Peak YoY movement for Long-Term Debt Issuances: plummeted 189.49% in 2018, then skyrocketed 159135.37% in 2020.
  • A 5-year view of Long-Term Debt Issuances shows it stood at -$370467.0 in 2017, then skyrocketed by 101.83% to $6794.0 in 2018, then surged by 181.5% to $19125.0 in 2019, then soared by 5116.22% to $997603.0 in 2020, then skyrocketed by 40.34% to $1.4 million in 2021.
  • Per Business Quant, the three most recent readings for SBFM's Long-Term Debt Issuances are $1.4 million (Q3 2021), $2.6 million (Q2 2021), and $1.2 million (Q1 2021).